2-287736-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001002919.3(ALKAL2):c.100G>A(p.Gly34Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000733 in 1,459,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001002919.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALKAL2 | NM_001002919.3 | c.100G>A | p.Gly34Arg | missense_variant | 2/6 | ENST00000403610.9 | NP_001002919.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALKAL2 | ENST00000403610.9 | c.100G>A | p.Gly34Arg | missense_variant | 2/6 | 1 | NM_001002919.3 | ENSP00000384604.3 | ||
ALKAL2 | ENST00000452023.1 | c.100G>A | p.Gly34Arg | missense_variant | 2/5 | 3 | ENSP00000389939.1 | |||
ENSG00000228643 | ENST00000427831.1 | n.164+622C>T | intron_variant | 3 | ||||||
ALKAL2 | ENST00000401489.6 | c.-51G>A | upstream_gene_variant | 3 | ENSP00000385214.2 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 151934Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000285 AC: 22AN: 77310Hom.: 0 AF XY: 0.000291 AC XY: 13AN XY: 44694
GnomAD4 exome AF: 0.0000505 AC: 66AN: 1307576Hom.: 0 Cov.: 33 AF XY: 0.0000388 AC XY: 25AN XY: 644588
GnomAD4 genome AF: 0.000270 AC: 41AN: 152042Hom.: 0 Cov.: 34 AF XY: 0.000323 AC XY: 24AN XY: 74326
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at